Shell Price Target Raised by Analysts Following ARC Resources Acquisition AutoNation Inc Analyst Report Suggests Potential in Evolving Automotive Retail Landscape Softcat Raises Annual Profit Outlook as AI Infrastructure Demand Surges Amid Chip Shortage ABB India Call Option and Delhivery Put Option Options Market Analysis Sun Pharma Reports 26 Net Profit Growth in Q4 Driven by Strong Sales and Strategic Investments US Payrolls Surge Past Expectations in April Yet Underlying Weak Spots Emerge Oxford Lane Capital Corp OXLCG Q4 2025 Earnings EPS Misses Estimates as Net Investment Income Falls Short SRXH Q2 2025 Earnings EPS Loss of 074 and No Revenue Reported Weigh on Sentiment SWVL Q4 2022 Earnings Narrower Loss Beats Expectations Stock Rises Ramaco Resources METC Q1 2026 Earnings EPS Misses Estimates by 4045 While Stock Gains SM Energy Q1 2026 Earnings Strong Earnings Beat Powers Shares Higher APH Q1 2026 Earnings Stellar EPS Surprise Drives Strong Stock Rally Hudson Pacific Properties HPP Rebounds Toward Resistance After Modest Gain Thor Industries THO Gains Nearly 2 as RV Maker Approaches Key Resistance KinderCare Learning KLC Drops 35 as Shares Test Support Zone Ekso Bionics EKSO Moves Higher as Stock Tests Resistance Near 1239 Zenta Group ZGM Holds Steady at 165 as Traders Weigh Support and Resistance Levels LeonaBio Inc LONA Rises 145 as Shares Approach Key Resistance at 103 DSS Inc DSS Edges Higher Testing Key Resistance at 053 Rain Enhancement Technologies RAIN Surges 6 as Momentum Builds Near Resistance Legence Corp LGN Surges 659 as Buyers Test Key Resistance Levels Crane NXT Co CXT Surges 262 as Shares Test Key Resistance Level Waters Corporation WAT Shows Modest Decline as Technical Levels Come into Focus European Telecom CEO Warns of US Satellite Dominance Risk to Continents Connectivity ACV Auctions ACVA Q1 2026 Earnings EPS Beat Signals Strengthening Cost Discipline Fortress Biotech FBIO Gains 29 as Stock Approaches Key Resistance Zone RTX Q1 2026 Earnings Solid EPS Beat Driven by Strong Commercial and Defense Demand Cadrenal Therapeutics Q1 2026 Earnings Narrowed Loss Surpasses Estimates Stock Edges Higher ASTE Q1 2026 Earnings Earnings Miss Disappoints as EPS Falls 367 Below Estimates ARCT Q1 2026 Earnings Arcturus Beats EPS Estimates Amid PreRevenue Phase Stock Edges Higher RILYK Q1 2024 Earnings A Quarter of Continued Losses and Modest Stock Uptick Falcons Beyond Global FBYD Q1 2026 Earnings Negative EPS Weighs on Shares Definitive Healthcare DH Q1 2026 Earnings EPS Beats Estimates by Wide Margin Stock Rises